Tuberculosis

Pai, Madhukar, Behr, Marcel A., Dowdy, David, Dheda, Keertan, Divangahi, Maziar, Boehme, Catharina C., Ginsberg, Ann, Swaminathan, Soumya +4 more·2016·Nature Reviews Disease Primers

Cited by (1,000)

Items 301–400 of 1,000

  1. On-Field Test of Tuberculosis Diagnosis through Exhaled Breath Analysis with a Gas Sensor Array
    Yolande Ketchanji Mougang, L.M. Endale Mangamba, Rosamaria Capuano, Fausto Ciccacci, Alexandro Catini, Roberto Paolesse, Bertrand Hugo Mbatchou Ngahane, Leonardo Palombi, Corrado Di Natale · 2023 · Biosensors
  2. Mycobacterium tuberculosis in a Trap: The Role of Neutrophil Extracellular Traps in Tuberculosis
    Luiz Henrique Agra Cavalcante Silva, Fernanda Silva Almeida, Arthur Gomes de Andrade, Fernando Cézar Comberlang, Leonardo Lima Cardoso, Shayenne Eduarda Ramos Vanderley, Tatjana Souza Lima Keesen · 2023 · International Journal of Molecular Sciences
  3. Mycobacterium tuberculosis Reporter Strains as Tools for Drug Discovery and Development
    Robert B. Abramovitch · 2018 · IUBMB Life
  4. Pre-clinical evaluation of quinoxaline-derived chalcones in tuberculosis
    Thaís Cristina Muradás, Bruno Lopes Abbadi, Anne Drumond Villela, Fernanda Souza Macchi, Pedro Bergo, Talita Freitas de Freitas, Nathalia Denise de Moura Sperotto, Luís Fernando Saraiva Macedo Timmers, Osmar Norberto de Souza, Jaqueline Nascimento Picada et al. · 2018 · PLoS ONE
  5. Comparing the Metabolic Capabilities of Bacteria in the Mycobacterium tuberculosis Complex
    Rachael A Fieweger, Kaley M. Wilburn, Brian C. VanderVen · 2019 · Microorganisms
  6. Structural Variability of EspG Chaperones from Mycobacterial ESX-1, ESX-3, and ESX-5 Type VII Secretion Systems
    Anne T. Tuukkanen, Diana Mendes Freire, Sum Chan, Mark A. Arbing, Robert W. Reed, Timothy J. Evans, Grasilda Zenkevičiūtė, Jennifer S. Kim, Sara Kahng, Michael R. Sawaya et al. · 2018 · Journal of Molecular Biology
  7. Comprehensive Insights Into Sulfanilamido‐Based Medicinal Design and Research
    Yixin Wang, Juan Wang, Lin‐Li Mou, H. Y. Zhang, Guang‐Ying Chen, Cheng‐He Zhou · 2025 · Medicinal Research Reviews
  8. Mycobacterium tuberculosis-Infected Hematopoietic Stem and Progenitor Cells Unable to Express Inducible Nitric Oxide Synthase Propagate Tuberculosis in Mice
    Stephen T. Reece, Alexis Vogelzang, Julia Tornack, Wolfgang Michael Bauer, Ulrike Zedler, Sandra Schommer-Leitner, Georg Stingl, Fritz Melchers, Stefan H. E. Kaufmann · 2018 · The Journal of Infectious Diseases
  9. Development of tuberculosis vaccines in clinical trials: Current status
    Patricia Méndez‐Samperio · 2018 · Scandinavian Journal of Immunology
  10. Detection and quantification of Mycobacterium tuberculosis antigen CFP10 in serum and urine for the rapid diagnosis of active tuberculosis disease
    Marva Seifert, Eva Vargas, Víctor Ruiz‐Valdepeñas Montiel, Joseph Wang, Timothy C. Rodwell, Antonino Catanzaro · 2021 · Scientific Reports
  11. Advances in the Application of 1,2,4-Triazole-Containing Hybrids as Anti-Tuberculosis Agents
    Yingdong Cao, Hong Lu · 2021 · Future Medicinal Chemistry
  12. BCG vaccination induces enhanced frequencies of memory T cells and altered plasma levels of common γc cytokines in elderly individuals
    Nathella Pavan Kumar, Chandrasekaran Padmapriyadarsini, Anuradha Rajamanickam, Perumal Kannabiran Bhavani, Arul Nancy, Bharathi Jayadeepa, Nandhini Selvaraj, Dinesh Asokan, Rachel Mariam Renji, Vijayalakshmi Venkataramani et al. · 2021 · PLoS ONE
  13. Transcript host-RNA signatures to discriminate bacterial and viral infections in febrile children
    Danilo Buonsenso, Giorgio Sodero, Piero Valentini · 2021 · Pediatric Research
  14. Study on the Influencing Factors of Knowledge, Attitudes and Practice About Tuberculosis Among Freshmen in Jiangsu, China: A Cross-Sectional Study
    Guoping Du, Chao Li, Yangyang Liu, Fulai Tu, Ruizhe Yang, Rui Li, Hongbing Shen, Wei Li · 2022 · Infection and Drug Resistance
  15. Tuberculosis-a World Health Organization Perspective
    Giovanni Sotgiu, Giorgia Sulis, Alberto Matteelli · 2017 · ASM Press eBooks
  16. Deciphering the emerging role of phytocompounds: Implications in the management of drug-resistant tuberculosis and ATDs-induced hepatic damage
    Mohammad Azam Ansari, Shoaib Shoaib, Mohammad N. Alomary, Hissana Ather, Shaik Mohammad Asif Ansari, Umme Hani, Yahya Fahad Jamous, Sami A. Alyahya, Jameela Naif Alharbi, Mohammad Azhar Imran et al. · 2023 · Journal of Infection and Public Health
  17. Evaluation of minor groove binders (MGBs) as novel anti-mycobacterial agents and the effect of using non-ionic surfactant vesicles as a delivery system to improve their efficacy
    Lerato Hlaka, Michael-Jon Rosslee, Mumin Ozturk, Santosh Kumar, Suraj P. Parihar, Frank Brombacher, Abedawn I. Khalaf, Katharine C. Carter, Fraser J. Scott, Colin J. Suckling et al. · 2017 · Journal of Antimicrobial Chemotherapy
  18. Designing tuberculosis vaccine efficacy trials – lessons from recent studies
    Ann M. Ginsberg · 2019 · Expert Review of Vaccines
  19. Heightened systemic levels of anti-inflammatory cytokines in pulmonary tuberculosis and alterations following anti-tuberculosis treatment
    Kadar Moideen, Nathella Pavan Kumar, Ramalingam Bethunaickan, Vaithilingam V. Banurekha, Dina Nair, Subash Babu · 2019 · Cytokine
  20. Multinucleated Giant Cell Formation as a Portal to Chronic Bacterial Infections
    Jacob L. Stockton, Alfredo G. Torres · 2020 · Microorganisms
  21. Ferroptosis-related gene SOCS1, a marker for tuberculosis diagnosis and treatment, involves in macrophage polarization and facilitates bone destruction in tuberculosis
    Tuo Liang, Jiarui Chen, Guoyong Xu, Zide Zhang, Jiang Xue, Haopeng Zeng, Jie Jiang, Tianyou Chen, Zhaojie Qin, Hao Li et al. · 2021 · Tuberculosis
  22. Mannosamine-Engineered Nanoparticles for Precision Rifapentine Delivery to Macrophages: Advancing Targeted Therapy Against Mycobacterium Tuberculosis
    Haopeng Luan, Cong Peng, Parhat Yasin, Qisong Shang, Wei Xiang, Xinghua Song · 2025 · Drug Design Development and Therapy
  23. Novel thiazolidinedione-hydroxamates as inhibitors of Mycobacterium tuberculosis virulence factor Zmp1
    Veronika Šlachtová, Marek Šebela, Eveline Torfs, Lauren Oorts, Davie Cappoen, Karel Berka, Václav Bazgier, Lucie Brulíková · 2019 · European Journal of Medicinal Chemistry
  24. CD4 T Cells in Mycobacterium tuberculosis and Schistosoma mansoni Co-infected Individuals Maintain Functional TH1 Responses
    Taryn A. McLaughlin, Jeremiah Khayumbi, Joshua Ongalo, Joan Tonui, Angela Campbell, Salim Allana, Samuel Gurrion Ouma, Felix Hayara Odhiambo, Neel R. Gandhi, Cheryl L. Day · 2020 · Frontiers in Immunology
  25. Automated Tuberculosis Detection Using Pre-Trained CNN and SVM
    Burcu Oltu, Selda Güney, Berna Dengiz, Ahmet Muhteşem Ağıldere · 2021 · International Conference on Telecommunications and Signal Processing (TSP)
  26. Understanding the pathogenesis of infectious diseases by single-cell RNA sequencing
    Wanqiu Huang, Danni Wang, Yufeng Yao · 2021 · Microbial Cell
  27. Cationic inhalable particles for enhanced drug delivery to M. tuberculosis infected macrophages
    Pallavi Raj Sharma, Ameya Atul Dravid, Yeswanth Chakravarthy Kalapala, Vishal K. Gupta, Sharumathi Jeyasankar, Avijit Goswami, Rachit Agarwal · 2021 · Biomaterials Advances
  28. Anti-tubercular activity of novel 4-anilinoquinolines and 4-anilinoquinazolines
    Christopher R. M. Asquith, Neil D. Fleck, Chad Torrice, Daniel James Crona, Christoph Grundner, William J. Zuercher · 2019 · Bioorganic & Medicinal Chemistry Letters
  29. Genomic Polymorphism Associated with the Emergence of Virulent Isolates of Mycobacterium bovis in the Nile Delta
    Hazem F. M. Abdelaal, Daniel Spalink, Ali Amer, Howard N. Steinberg, Emad A. Hashish, Essam Amin Nasr, Adel M. Talaat · 2019 · Scientific Reports
  30. Persistent Mycobacterium tuberculosis infection in mice requires PerM for successful cell division
    Ruojun Wang, Kaj M. Kreutzfeldt, Hélène Botella, Julien Vaubourgeix, Dirk Schnappinger, Sabine Ehrt · 2019 · eLife
  31. Design, synthesis and biological evaluation of diamino substituted cyclobut-3-ene-1,2-dione derivatives for the treatment of drug-resistant tuberculosis
    Peng Li, Bin Wang, Gang Li, Lei Fu, Dongfeng Zhang, Ziyun Lin, Haihong Huang, Yu Lu · 2020 · European Journal of Medicinal Chemistry
  32. Insight into diagnosis of female genital tuberculosis
    Bhawna Dahiya, Ekta Kamra, Danish Alam, Meenakshi Barsaul Chauhan, Promod K. Mehta · 2021 · Expert Review of Molecular Diagnostics
  33. Antitubercular activity of 2-mercaptobenzothiazole derivatives targeting Mycobacterium tuberculosis type II NADH dehydrogenase
    Pallavi Saha, Shashikanta Sau, Rohit Kumar, Nitin Pal Kalia, Deepak Kumar · 2024 · RSC Medicinal Chemistry
  34. Role of Tumor Necrosis Factor in Tuberculosis
    Киреев Федор Дмитриевич, Julia Lopatnikova, Alina Alshevskaya, Sergey Vitalievich Sennikov · 2025 · Biomolecules
  35. Human alveolar macrophage response to Mycobacterium tuberculosis: immune characteristics underlying large inter-individual variability
    Wolfgang Sadée, Ian H. Cheeseman, Audrey C. Papp, Maciej Pietrzak, Michał T. Seweryn, Xiaofei Zhou, Shili Lin, Amanda M. Williams, Mark Damian Wewers, Heather M. Curry et al. · 2025 · Communications Biology
  36. Comparative Evaluation of the Loop-Mediated Isothermal Amplification Assay for Detecting Pulmonary Tuberculosis
    Chang-Ki Kim, Eun A Cho, Dong Mi Shin, Sung Won Choi, So–Youn Shin · 2017 · Annals of Laboratory Medicine
  37. A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis
    Stéphane Leung–Theung–Long, Charles‐Antoine Coupet, Marie Gouanvic, Doris Schmitt, Aurelie A. Ray, Chantal Hoffmann, Huguette Schultz, Sandeep K. Tyagi, Heena Soni, Paul J. Converse et al. · 2018 · PLoS ONE
  38. Tuberculosis among asylum seekers in Milan, Italy: epidemiological analysis and evaluation of interventions
    Simone Villa, Luigi Ruffo Codecasa, Marino Faccini, Mirella Maria Pontello, Maurizio Ferrarese, Paola Francesca Castellotti, Sabrina Senatore, Anna Lamberti, Ester Mazzola, Carlo Federico Perno et al. · 2019 · European Respiratory Journal
  39. Colony-stimulating factor-1- and interleukin-34-derived macrophages differ in their susceptibility to Mycobacterium marinum
    Milan Popović, Amulya Yaparla, Dominic Paquin‐Proulx, Daphne V. Koubourli, Rose Webb, Marcia A. Firmani, Leon Grayfer · 2019 · Journal of Leukocyte Biology
  40. Light emitting diode (LED) based fluorescence microscopy for tuberculosis detection: a review
    Anushka Ojha, Soumyabrata Banik, Sindhoora Kaniyala Melanthota, Nirmal Mazumder · 2020 · Lasers in Medical Science
  41. Identification of differentially expressed lncRNAs as potential plasma biomarkers for active tuberculosis
    Yalun Fang, Jingjie Zhao, Xiaoyan Wang, Xinfeng Wang, Li Wang, Ling Liu, Junli Liu, Meng Gao, Chao Yuan · 2021 · Tuberculosis
  42. Mean platelet volume (MPV): new diagnostic indices for co-morbidity of tuberculosis and diabetes mellitus
    Feifan Xu, Shengyan Qu, Lin Wang, Yongwei Qin · 2021 · BMC Infectious Diseases
  43. Elevated IP-10 at the Protein and Gene Level Associates With Pulmonary TB
    Kimone L Fisher, Denelle Moodley, Kerishka Rajkumar-Bhugeloo, Omolara O. Baiyegunhi, Farina Karim, Hlumani Ndlovu, Thumbi Ndung’u, Mohlopheni Jackson Marakalala · 2022 · Frontiers in Cellular and Infection Microbiology
  44. Tuberculosis and Cardiovascular Complications: An Overview
    Mayowa A Adefuye, Nisha Manjunatha, Vinutna Ganduri, Kruthiga Rajasekaran, Shrimahitha Duraiyarasan, Bolanle Olufunlola Adefuye · 2022 · Cureus
  45. Immunological hyporesponsiveness in tuberculosis: The role of mycobacterial glycolipids
    Margarida Correia‐Neves, Jérôme Nigou, Zaynab Mousavian, Christopher Sundling, Gunilla Källenius · 2022 · Frontiers in Immunology
  46. Numerical Simulation of Surface Plasmon Resonance Optical Fiber Biosensor Enhanced by Using Alloys for Medical Application
    Parisa Esmailidastjerdipour, Fateme Shahshahani · 2023 · Sensing and Imaging
  47. IL-4 and helminth infection downregulate MINCLE-dependent macrophage response to mycobacteria and Th17 adjuvanticity
    Judith Schick, Meltem Altunay, Matthew Lacorcia, Nathalie Marschner, Stefanie Westermann, Julia Schluckebier, Christoph Schubart, Barbara Bodendorfer, Dennis Christensen, Christian Alexander et al. · 2023 · eLife
  48. Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3‐Triazoles: A Computational Docking Techniques
    Kumaraswamy Sadineni, Sravanthi Basireddy, Tejeswara Rao Allaka, Satyanarayana Yatam, Srinu Bhoomandla, Venkatanaryana Muvvala, Sharath Babu Haridasyam · 2024 · Chemistry & Biodiversity
  49. Using a Fragment-Based Approach to Identify Alternative Chemical Scaffolds Targeting Dihydrofolate Reductase from Mycobacterium tuberculosis
    João Augusto Ribeiro, Alexander J. S. Hammer, Gerardo Andrés Libreros-Zúñiga, S.M. Chavez-Pacheco, Petros A. Tyrakis, Gabriel Stephani de Oliveira, Timothy Kirkman, Jamal El Bakali, Silvana Aparecida Rocco, Mauricio Luis Sforça et al. · 2020 · ACS Infectious Diseases
  50. TBscreen: A passive cough classifier for tuberculosis screening with a controlled dataset
    Manuja Sharma, Videlis Nduba, Lilian N. Njagi, Wilfred Bundi Murithi, Zipporah Mwongera, Thomas R. Hawn, Shwetak Patel, David J. de L. Horne · 2024 · Science Advances
  51. On BCG Vaccine Protection from COVID-19: A Review
    Narges Bagheri, Hesam Montazeri · 2021 · SN Comprehensive Clinical Medicine
  52. Antibacterial polyene-polyol macrolides and cyclic peptides from the marine-derived Streptomyces sp. MS110128
    Lan Jiang, Pei Huang, Biao Ren, Zhijun Song, Guoliang Zhu, Wenni He, Jingyu Zhang, Ayokunmi Oyeleye, Huanqin Dai, Lixin Zhang et al. · 2021 · Applied Microbiology and Biotechnology
  53. Increased UBE2L6 regulated by type 1 interferon as potential marker in TB
    Jiao Gao, Chonghui Li, Wenjing Li, Haotian Chen, Yurong Fu, Zhengjun Yi · 2021 · Journal of Cellular and Molecular Medicine
  54. Discovery of 3H-pyrrolo[2,3-c]quinolines with activity against Mycobacterium tuberculosis by allosteric inhibition of the glutamate-5-kinase enzyme
    Michele Panciera, Emilio Lence, Ángela Rodríguez, Begoña Gracia, José Antonio Aínsa, Clara Marco‐Marín, Vicente Rubio, Carlos Roque D. Correia, Concepción González‐Bello · 2022 · European Journal of Medicinal Chemistry
  55. Connecting the dots: understanding how human mobility shapes TB epidemics
    Tyler S. Brown, D. Ashley Robinson, Caroline O. Buckee, Barun Mathema · 2022 · Trends in Microbiology
  56. Identification of immune biomarkers in recent active pulmonary tuberculosis
    Sobia Naz Shaukat, Eliseo A. Eugenín, Faizan Nasir, Rafiq Khanani, Shahana Urooj Kazmi · 2023 · Scientific Reports
  57. The Mycobacterium tuberculosis Cell Wall: An Alluring Drug Target for Developing Newer Anti‐ TB Drugs—A Perspective
    Monica Chauhan, Rahul R. Barot, Rasana Yadav, Karan D. Joshi, S. A. Mirza, Rupesh V. Chikhale, Vijay Kumar Srivastava, Mange Ram Yadav, Prashant Revan Murumkar · 2024 · Chemical Biology & Drug Design
  58. The association between Bacillus Calmette-Guérin vaccination (1331 SSI) skin reaction and subsequent scar development in infants
    Nina Marie Birk, Thomas Nørrelykke Nissen, Monica Ladekarl, Vera Zingmark, Jesper Kjærgaard, Trine Mølbæk Jensen, Signe Kjeldgaard Jensen, Lisbeth Marianne Thøstesen, Poul‐Erik Kofoed, Lone Graff Stensballe et al. · 2017 · BMC Infectious Diseases
  59. Dual-targeting GroEL/ES chaperonin and protein tyrosine phosphatase B (PtpB) inhibitors: A polypharmacology strategy for treating Mycobacterium tuberculosis infections
    Alex Washburn, Sanofar Jainul Abdeen, Yulia Ovechkina, Anne‐Marie Ray, Mckayla Stevens, Siddhi Chitre, Jared Sivinski, Yangshin Park, James Johnson, Quyen Q. Hoang et al. · 2019 · Bioorganic & Medicinal Chemistry Letters
  60. Mycobacterium tuberculosisESAT6 Drives the Activation and Maturation of Bone Marrow-Derived Dendritic Cells via TLR4-Mediated Signaling
    Ah‐Ra Jang, Green Kim, Jung Joo Hong, Soon Myung Kang, Sung Jae Shin, Jong‐Hwan Park · 2019 · Immune Network
  61. Artificial intelligence in tuberculosis: a new ally in disease control
    M. McClean, Traian Constantin Panciu, Christoph G. Lange, Raquel Duarte, Fabian Joachim Theis · 2024 · Breathe
  62. Use of Antiplatelet Agents and Survival of Tuberculosis Patients: A Population-Based Cohort Study
    Meng‐Rui Lee, Ming‐Chia Lee, Chia‐Hao Chang, Chia-Jung Liu, Lih‐Yu Chang, Junfu Zhang, Jann‐Yuan Wang, Chih‐Hsin Lee · 2019 · Journal of Clinical Medicine
  63. Incidence rate of active tuberculosis in solid organ transplant recipients: Data from a nationwide population cohort in a high‐endemic country
    Da Eun Kwon, Sang Hoon Han, Kyungdo Han, Yeonju La, Kyoung Hwa Lee · 2021 · Transplant Infectious Disease
  64. The Dynamic Change of Immune Checkpoints and CD14+ Monocytes in Latent Tuberculosis Infection
    Ping-Huai Wang, Ming‐Fang Wu, Chi-Yu Hsu, Shu‐Yung Lin, Yanan Chang, Ho-Sheng Lee, Yu‐Feng Wei, Chin‐Chung Shu · 2021 · Biomedicines
  65. Acute Phase Proteins Are Baseline Predictors of Tuberculosis Treatment Failure
    Nathella Pavan Kumar, Kadar Moideen, Arul Nancy, Vijay Viswanathan, Kannan Thiruvengadam, Shanmugam Sivakumar, Syed S Hissar, Hardy Kornfeld, Subash Babu · 2021 · Frontiers in Immunology
  66. Spatial Modeling of Mycobacterium Tuberculosis Transmission with Dyadic Genetic Relatedness Data
    Joshua L. Warren, Melanie H. Chitwood, Benjamin Sobkowiak, Caroline Colijn, Ted Cohen · 2023 · Biometrics
  67. MMP9 and STAT1 are biomarkers of the change in immune infiltration after anti-tuberculosis therapy, and the immune status can identify patients with spinal tuberculosis
    Chenxing Zhou, Tuo Liang, Jie Jiang, Jiarui Chen, Tianyou Chen, Shengsheng Huang, Liyi Chen, Xuhua Sun, Wenkang Chen, Jichong Zhu et al. · 2023 · International Immunopharmacology
  68. Vaccine development against tuberculosis before and after Covid-19
    Stefan H. E. Kaufmann · 2023 · Frontiers in Immunology
  69. Micro-nanoemulsion and nanoparticle-assisted drug delivery against drug-resistant tuberculosis: recent developments
    Simpal Kumar Suman, Natarajan Chandrasekaran, C. George Priya Doss · 2023 · Clinical Microbiology Reviews
  70. Targeting Mycobacterium tuberculosis Persistence through Inhibition of the Trehalose Catalytic Shift
    Karishma Kalera, Rachel Liu, Ju‐Hyeon Lim, Rasangi Pathirage, Daniel H. Swanson, Ulysses G. Johnson, Alicyn I. Stothard, Jae Jin Lee, Anne W. Poston, Peter J. Woodruff et al. · 2024 · ACS Infectious Diseases
  71. Implications of subclinical tuberculosis for vaccine trial design and global effect
    Gavin Churchyard, Rein M G J Houben, Katherine Fielding, Andrew L Fiore-Gartland, Hanif Esmail, Alison D. Grant, Molebogeng Xheedha Rangaka, Marcel A. Behr, Alberto L. García‐Basteiro, Emily Beth Wong et al. · 2024 · The Lancet Microbe
  72. An Accord of Nuclear Receptor Expression in M. tuberculosis Infected Macrophages and Dendritic Cells
    Ankita Saini, Sahil Mahajan, Nancy Ahuja, Ella Bhagyaraj, Rashi Kalra, Ashok Kumar Janmeja, Pawan Kumar Gupta · 2018 · Scientific Reports
  73. Measuring and reporting treatment adherence: What can we learn by comparing two respiratory conditions?
    Holly Tibble, Mary Flook, Aziz Sheikh, Athanasios Tsanas, Robert Horne, Bernard Vrijens, Sabina De Geest, Helen Ruth Stagg · 2020 · British Journal of Clinical Pharmacology
  74. Vitamin D – A host directed autophagy mediated therapy for tuberculosis
    Krisna Moorthi Periyasamy, Uma Devi Ranganathan, Srikanth Prasad Tripathy, Ramalingam Bethunaickan · 2020 · Molecular Immunology
  75. Tuberculosis in Australia's tropical north: a population-based genomic epidemiological study
    Ella M. Meumann, Kristy Horan, Anna P. Ralph, Belinda Farmer, Maria Globan, Elizabeth Stephenson, Tracy Popple, Rowena Boyd, Mirjam Kaestli, Torsten Seemann et al. · 2021 · The Lancet Regional Health - Western Pacific
  76. Mitochondrial Transplantation Promotes Protective Effector and Memory CD4 + T Cell Response During Mycobacterium Tuberculosis Infection and Diminishes Exhaustion and Senescence in Elderly CD4 + T cells
    Colwyn Ansel Headley, Shalini Gautam, Angélica M. Olmo-Fontánez, Andreu Garcia‐Vilanova, Varun Dwivedi, Alyssa Schami, Susan T. Weintraub, Philip S. Tsao, Jordi Bertran Torrelles, Joanne Turner · 2024 · Advanced Science
  77. Advancing the fight against tuberculosis: integrating innovation and public health in diagnosis, treatment, vaccine development, and implementation science
    Ayman Elbehiry, Eman Marzouk, Husam M. Edrees, Riyad AlShaqi, Abousree Taha Ellethy, Feras Alzaben, Sulaiman Abdulaziz Anagreyyah, Ahmad Algarni, Khalid Almuhaydili, Ibrahim Abdullah Bijad AlOtaibi et al. · 2025 · Frontiers in Medicine
  78. Tuberculosis: the story after the Primer
    Madhukar Pai · 2020 · Nature Reviews Disease Primers
  79. Past and Present Approaches to Diagnosis of Active Pulmonary Tuberculosis
    Anna Ritah Namuganga, Novel N. Chegou, Harriet Mayanja‐Kizza · 2021 · Frontiers in Medicine
  80. Dual RNA Sequencing of Mycobacterium tuberculosis-Infected Human Splenic Macrophages Reveals a Strain-Dependent Host–Pathogen Response to Infection
    Víctor A. López-Agudelo, Andrés Baena, Vianey Paola Barrera Enriquez, Felipe Cabarcas, Juan F. Álzate, Dany J. V. Beste, Rigoberto Ríos‐Estepa, Luis Fernando Barrera · 2022 · International Journal of Molecular Sciences
  81. Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses
    Alba Llibre, Nikaïa Smith, Vincent Rouilly, Munyaradzi Musvosvi, Elisa Nemes, Céline Posseme, Simbarashe Mabwe, Bruno Charbit, Stanley Kimbung Mbandi, Elizabeth Filander et al. · 2022 · Frontiers in Immunology
  82. Development of CRISPR/Cas12b-Based Multiple Cross Displacement Amplification Technique for the Detection of Mycobacterium tuberculosis Complex in Clinical Settings
    Xinggui Yang, Junfei Huang, Yijiang Chen, Xia Ying, Qinqin Tan, Xu Chen, Xiaoyan Zeng, Shiguang Lei, Yi Wang, Shijun Li · 2023 · Microbiology Spectrum
  83. Tuberculosis — drugs in the 2016 development pipeline
    Barbara E. Laughon, Carol A. Nacy · 2017 · Nature Reviews Disease Primers
  84. Scenario analysis for programmatic tuberculosis control in Bangladesh: a mathematical modelling study
    Md Abdul Kuddus, Michael T. Meehan, Md. Abu Sayem, Emma Sue McBryde · 2021 · Scientific Reports
  85. Single-Nucleotide Variants in the AIM2 – Absent in Melanoma 2 Gene (rs1103577) Associated With Protection for Tuberculosis
    Mariana Brasil de Andrade Figueira, Dhêmerson Souza de Lima, Antônio Luiz Boechat, Milton Gomes do Nascimento Filho, Irineide Assumpção Antunes, Joycenéa da Silva Matsuda, Thaís Rodrigues de Albuquerque Ribeiro, Luana Sousa Felix, Ariane Senna Fonseca Gonçalves, Allyson Guimarães Costa et al. · 2021 · Frontiers in Immunology
  86. A Pandemic within Other Pandemics. When a Multiple Infection of a Host Occurs: SARS-CoV-2, HIV and Mycobacterium tuberculosis
    Carmen María González-Domenech, Isabel A Pérez‐Hernández, Cristina Gómez‐Ayerbe, Isabel Viciana, Rosario Palacios Muñoz, Jesus S. Santos · 2021 · Viruses
  87. Is the New Interferon-Gamma Releasing Assay Beneficial for the Diagnosis of Latent and Active Mycobacterium tuberculosis Infections in Tertiary Care Setting?
    Jae-Wan Jung, Byung Woo Jhun, Mijeong Jeong, Sun Joo Yoon, Hee Jae Huh, Chul Won Jung, Kihyun Kım, Jae Berm Park, Dae Joong Kim, Wooseong Huh et al. · 2021 · Journal of Clinical Medicine
  88. The Epidemiological Characteristics of Pulmonary Tuberculosis — Kashgar Prefecture, Xinjiang Uygur Autonomous Region, China, 2011–2020
    Diermulati Tusun, Tuberculosis Dispensary of Kashgar Prefecture, Kashgar, Xinjiang Uygur Autonomous Region, China, Maiweilanjiang Abulimiti, Xirizhati Mamuti, Zhenjiang Liu, Da Xu, Guanzhen Li, Xiaowang Peng, Tuerhong Abudureyimu, Lijie Zhang et al. · 2021 · China CDC Weekly
  89. Understanding the Decline of Incident, Active Tuberculosis in People With Human Immunodeficiency Virus in Switzerland
    Marius Zeeb, Burcu Tepekule, Katharina Kusejko, Claudine Reiber, Marisa Kälin, Lena Bartl, Julia Notter, Hansjakob Furrer, Matthias Hoffmann, Hans Hellmuth Hirsch et al. · 2023 · Clinical Infectious Diseases
  90. Genomic epidemiology analysis of drug-resistant Mycobacterium tuberculosis distributed in Mexico
    Paulina M. Mejía‐Ponce, Elsy Janeth Ramos-González, Axel Alejandro Ramos-García, Edgar Eduardo Lara-Ramirez, Alma R. Soriano-Herrera, Mitzzy F. Medellín-Luna, Fernando Valdez-Salazar, Claudia Y. Castro-Garay, José J. Núñez-Contreras, Marcos De Donato et al. · 2023 · PLoS ONE
  91. Pangenome databases improve host removal and mycobacteria classification from clinical metagenomic data
    Michael B. Hall, Lachlan Coin · 2024 · GigaScience
  92. Development of NMR and thermal shift assays for the evaluation of Mycobacterium tuberculosis isocitrate lyase inhibitors
    Ram Prasad Bhusal, Krunal Patel, Brooke X. C. Kwai, Anne Swartjes, Ghader Bashiri, Jóhannes Reynisson, Jonathan Sperry, Ivanhoe K. H. Leung · 2017 · MedChemComm
  93. Cracking the Vaccine Code in Tuberculosis
    Maziar Divangahi, Marcel A. Behr · 2017 · American Journal of Respiratory and Critical Care Medicine
  94. Patho-epigenetics: histone deacetylases as targets of pathogens and therapeutics
    Daniel Schator, Laura Gómez-Valero, Carmen Buchrieser, Monica Rolando · 2021 · microLife
  95. Factors Associated with the Abandonment of Tuberculosis Treatment in Brazil: A Systematic Review
    Larissa Araújo de Lucena, Gabriela Bezerra da Silva Dantas, Taynara Vieira Carneiro, Hênio Godeiro Lacerda · 2023 · Revista da Sociedade Brasileira de Medicina Tropical
  96. New management approaches to tuberculosis in people living with HIV
    David V. Mhango, David Twapokera Mzinza, Kondwani Jambo, Henry Charles Mwandumba · 2020 · Current Opinion in Infectious Diseases
  97. A biocompatible dual-AIEgen system without spectral overlap for quantitation of microbial viability and monitoring of biofilm formation
    Wei He, Zheng Zheng, Haotian Bai, Ling‐Hong Xiong, Lei Wang, Yinghui Li, Ryan T. K. Kwok, Jacky W. Y. Lam, Qinghua Hu, Jinquan Cheng et al. · 2021 · Materials Horizons
  98. Treating latent tuberculosis infection (LTBI) with isoniazid and rifapentine (3HP) in an inner-city population with psychosocial barriers to treatment adherence: A qualitative descriptive study
    Amber Heyd, Courtney Heffernan, Kate Storey, T. Cameron Wild, Richard Long · 2021 · PLOS Global Public Health
  99. A Systematic Review of Economic Evaluations of Active Tuberculosis Treatments
    Joo‐Young Byun, Hye‐Lin Kim, Eui‐Kyung Lee, Sun‐Hong Kwon · 2021 · Frontiers in Pharmacology
  100. Identifying RO9021 as a Potential Inhibitor of PknG from Mycobacterium tuberculosis : Combinative Computational and In Vitro Studies
    Alicia Arica-Sosa, Roberto Alcántara, Gabriel Jiménez-Avalos, Mirko Zimic, Pohl Milón, Miguel Quiliano · 2022 · ACS Omega